SG11201507310VA - Antiviral indolo[2,3-b]quinoxaline - Google Patents
Antiviral indolo[2,3-b]quinoxalineInfo
- Publication number
- SG11201507310VA SG11201507310VA SG11201507310VA SG11201507310VA SG11201507310VA SG 11201507310V A SG11201507310V A SG 11201507310VA SG 11201507310V A SG11201507310V A SG 11201507310VA SG 11201507310V A SG11201507310V A SG 11201507310VA SG 11201507310V A SG11201507310V A SG 11201507310VA
- Authority
- SG
- Singapore
- Prior art keywords
- indolo
- quinoxaline
- antiviral
- antiviral indolo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361788867P | 2013-03-15 | 2013-03-15 | |
| PCT/EP2014/055178 WO2014140321A1 (en) | 2013-03-15 | 2014-03-14 | Antiviral indolo[2,3-b]quinoxaline |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201507310VA true SG11201507310VA (en) | 2015-10-29 |
Family
ID=50280403
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201507310VA SG11201507310VA (en) | 2013-03-15 | 2014-03-14 | Antiviral indolo[2,3-b]quinoxaline |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20160031889A1 (pt) |
| EP (1) | EP2970292A1 (pt) |
| JP (1) | JP2016510798A (pt) |
| KR (1) | KR20150130463A (pt) |
| CN (1) | CN105102459A (pt) |
| AU (1) | AU2014230133A1 (pt) |
| BR (1) | BR112015022134A2 (pt) |
| CA (1) | CA2904468A1 (pt) |
| CL (1) | CL2015002730A1 (pt) |
| EA (1) | EA201500942A1 (pt) |
| HK (1) | HK1220196A1 (pt) |
| IL (1) | IL241364A0 (pt) |
| MX (1) | MX2015011387A (pt) |
| SG (1) | SG11201507310VA (pt) |
| WO (1) | WO2014140321A1 (pt) |
| ZA (1) | ZA201507151B (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230226048A1 (en) * | 2020-06-10 | 2023-07-20 | Cyxone Ab | New use of rabeximod |
| WO2022002898A1 (en) * | 2020-06-29 | 2022-01-06 | Vironova Medical Ab | 6h-indolo(2,3-b)quinoxaline derivatives useful in therapy in particular in a virus infection |
| CN116323614A (zh) | 2020-09-21 | 2023-06-23 | 维洛诺瓦医药公司 | 用于治疗炎性和自身免疫性病症的rabeximod的硫羰酯衍生物 |
| US11643415B1 (en) * | 2021-12-09 | 2023-05-09 | Cyxone Ab | Rabeximod compounds |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE527639C2 (sv) * | 2004-06-17 | 2006-05-02 | Oxypharma Ab | Alkylsubstituerade indolokinoxaliner |
-
2014
- 2014-03-14 JP JP2015562235A patent/JP2016510798A/ja active Pending
- 2014-03-14 KR KR1020157028480A patent/KR20150130463A/ko not_active Application Discontinuation
- 2014-03-14 EP EP14710286.7A patent/EP2970292A1/en not_active Withdrawn
- 2014-03-14 BR BR112015022134A patent/BR112015022134A2/pt not_active IP Right Cessation
- 2014-03-14 CN CN201480015143.8A patent/CN105102459A/zh active Pending
- 2014-03-14 MX MX2015011387A patent/MX2015011387A/es unknown
- 2014-03-14 US US14/775,310 patent/US20160031889A1/en not_active Abandoned
- 2014-03-14 CA CA2904468A patent/CA2904468A1/en not_active Abandoned
- 2014-03-14 AU AU2014230133A patent/AU2014230133A1/en not_active Abandoned
- 2014-03-14 WO PCT/EP2014/055178 patent/WO2014140321A1/en active Application Filing
- 2014-03-14 SG SG11201507310VA patent/SG11201507310VA/en unknown
- 2014-03-14 EA EA201500942A patent/EA201500942A1/ru unknown
-
2015
- 2015-09-09 IL IL241364A patent/IL241364A0/en unknown
- 2015-09-15 CL CL2015002730A patent/CL2015002730A1/es unknown
- 2015-09-28 ZA ZA2015/07151A patent/ZA201507151B/en unknown
-
2016
- 2016-07-15 HK HK16108314.4A patent/HK1220196A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1220196A1 (zh) | 2017-04-28 |
| ZA201507151B (en) | 2017-01-25 |
| EP2970292A1 (en) | 2016-01-20 |
| IL241364A0 (en) | 2015-11-30 |
| BR112015022134A2 (pt) | 2017-07-18 |
| CL2015002730A1 (es) | 2016-07-01 |
| JP2016510798A (ja) | 2016-04-11 |
| MX2015011387A (es) | 2016-06-10 |
| AU2014230133A1 (en) | 2015-11-05 |
| WO2014140321A1 (en) | 2014-09-18 |
| KR20150130463A (ko) | 2015-11-23 |
| US20160031889A1 (en) | 2016-02-04 |
| CN105102459A (zh) | 2015-11-25 |
| CA2904468A1 (en) | 2014-09-18 |
| EA201500942A1 (ru) | 2016-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS2300040I1 (hu) | Pirrolo[2,3-d]pirimidinil-, pirrolo[2,3-b]pirazinil- és pirrolo[2,3-d]-piridinil- akrilamidok | |
| HK1246792A1 (zh) | 6，7-二氫吡唑並[1，5-a]吡嗪-4(5h)-酮化合物 | |
| HK1219277A1 (zh) | 新的三唑並 嘧啶衍生物 | |
| ZA201506570B (en) | 2-phenylimidazo[1,2-a]pyrimidines as imaging agents | |
| IL234485A (en) | Compounds based on imidazo [2,1 – b] pyridazine | |
| IL250823A0 (en) | A new derivative of 6,5-dihydro-h4-benzo[b]thiano-[3,2-d]azepine | |
| AP2015008867A0 (en) | 3,4-dihydroisquinolin-2(1h)-yl compounds | |
| HK1223921A1 (zh) | 新的八氫-環丁二烯並 ; 二吡咯- | |
| SI2963043T1 (sl) | Derivat tetrahidroimidazo(1,5-d)(1,4)oksazepina | |
| ZA201605666B (en) | Pyrazolo[1,5-a]pyrimidines as antiviral compounds | |
| EP2970278A4 (en) | Pyrrolo [2,3] PYRIDINE KINASE INHIBITORS CDK9- | |
| ZA201406323B (en) | Triazolo[4,5-d]pyrimidine derivatives | |
| HK1216749A1 (zh) | -萘啶衍生物 | |
| EP2908841A4 (en) | NEW ANTIVIRAL MACROCYCLES | |
| HK1220196A1 (zh) | 抗病毒吲哚並 喹喔啉 | |
| HK1225860A1 (zh) | 帶有非導電的結構化表面的電池 | |
| GB201300892D0 (en) | Novel isothiazolo[4,3-b]pyridines | |
| GB201211756D0 (en) | Novel isothiazolo [4,3-b]pyridines |